120 related articles for article (PubMed ID: 11367565)
1. Photochemistry of 2-hydroxy-4-trifluoromethylbenzoic acid, major metabolite of the photosensitizing platelet antiaggregant drug triflusal.
Boscá F; Cuquerella MC; Marín ML; Miranda MA
Photochem Photobiol; 2001 May; 73(5):463-8. PubMed ID: 11367565
[TBL] [Abstract][Full Text] [Related]
2. Photonucleophilic addition of the epsilon-amino group of lysine to a triflusal metabolite as a mechanistic key to photoallergy mediated by the parent drug.
Montanaro S; Lhiaubet-Vallet V; Jiménez MC; Blanca M; Miranda MA
ChemMedChem; 2009 Jul; 4(7):1196-202. PubMed ID: 19462393
[TBL] [Abstract][Full Text] [Related]
3. Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes.
de la Cruz JP; Pavia J; Bellido I; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):363-7. PubMed ID: 3412046
[TBL] [Abstract][Full Text] [Related]
4. Binding of a metabolite of triflusal (2-hydroxy-4-trifluoromethylbenzoic acid) to serum proteins in rat and man.
Mis R; Ramis J; Conte L; Forn J
Eur J Clin Pharmacol; 1992; 42(2):175-9. PubMed ID: 1618249
[TBL] [Abstract][Full Text] [Related]
5. Photosensitivity to Triflusal: Formation of a Photoadduct with Ubiquitin Demonstrated by Photophysical and Proteomic Techniques.
Nuin E; Pérez-Sala D; Lhiaubet-Vallet V; Andreu I; Miranda MA
Front Pharmacol; 2016; 7():277. PubMed ID: 27621705
[TBL] [Abstract][Full Text] [Related]
6. Photobinding of Triflusal to Human Serum Albumin Investigated by Fluorescence, Proteomic Analysis, and Computational Studies.
Molins-Molina O; Pérez-Ruiz R; Lence E; González-Bello C; Miranda MA; Jiménez MC
Front Pharmacol; 2019; 10():1028. PubMed ID: 31616294
[TBL] [Abstract][Full Text] [Related]
7. In-vitro protein binding interaction between a metabolite of triflusal, 2-hydroxy-4-trifluoromethylbenzoic acid and other drugs.
Mis R; Ramis J; Conte L; Forn J
J Pharm Pharmacol; 1992 Nov; 44(11):935-7. PubMed ID: 1361542
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of triflusal after single and repeated doses in man.
Ramis J; Torrent J; Mis R; Conte L; Barbanoj MJ; Jané J; Forn J
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):344-9. PubMed ID: 2272716
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.
González-Correa JA; Arrebola MM; Ureña IM; Ruiz-Villafranca D; Muñoz-Marín J; Guerrero A; Sánchez de la Cuesta F; De La Cruz JP
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):81-8. PubMed ID: 15602657
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.
Planavila A; Rodríguez-Calvo R; de Arriba AF; Sánchez RM; Laguna JC; Merlos M; Vazquez-Carrera M
Mol Pharmacol; 2006 Apr; 69(4):1174-81. PubMed ID: 16421291
[TBL] [Abstract][Full Text] [Related]
11. Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets.
García-Rafanell J; Ramis J; Gomez L; Forn J
Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):155-65. PubMed ID: 3030206
[TBL] [Abstract][Full Text] [Related]
12. The stability of 2-acetoxy-4-trifluoromethylbenzoic acid (Triflusal) in micellar pseudophase.
Ferrit M; Del Valle C; López M; Luque R; Martínez F
J Pharm Sci; 2004 Feb; 93(2):461-9. PubMed ID: 14705202
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopic and chromatographic characterization of triflusal delivery systems prepared by using supercritical impregnation technologies.
Argemí A; López-Periago A; Domingo C; Saurina J
J Pharm Biomed Anal; 2008 Feb; 46(3):456-62. PubMed ID: 18093783
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic studies on the interaction between silicotungstic acid and bovine serum albumin.
Wang YQ; Zhang HM; Zhang GC; Tao WH; Fei ZH; Liu ZT
J Pharm Biomed Anal; 2007 Apr; 43(5):1869-75. PubMed ID: 17280811
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils.
Sánchez de Miguel L; Casado S; Farré J; García-Durán M; Rico LA; Montón M; Romero J; Bellver T; Sierra MP; Guerra JI; Mata P; Esteban A; López-Farré A
Eur J Pharmacol; 1998 Feb; 343(1):57-65. PubMed ID: 9551715
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.
Ramis J; Mis R; Forn J; Torrent J; Gorina E; Jané F
Eur J Drug Metab Pharmacokinet; 1991; 16(4):269-73. PubMed ID: 1823870
[TBL] [Abstract][Full Text] [Related]
17. Photobinding of tiaprofenic acid and suprofen to proteins and cells: a combined study using radiolabeling, antibodies and laser flash photolysis of model bichromophores.
Castell JV; Hernández D; Gómez-Lechón MJ; Lahoz A; Miranda MA; Morera IM; Pérez-Prieto J; Sarabia Z
Photochem Photobiol; 1998 Nov; 68(5):660-5. PubMed ID: 9825695
[TBL] [Abstract][Full Text] [Related]
18. Triplet- vs. singlet-state imposed photochemistry. The role of substituent effects on the photo-Fries and photodissociation reaction of triphenylmethyl silanes.
Zarkadis AK; Georgakilas V; Perdikomatis GP; Trifonov A; Gurzadyan GG; Skoulika S; Siskos MG
Photochem Photobiol Sci; 2005 Jun; 4(6):469-80. PubMed ID: 15920631
[TBL] [Abstract][Full Text] [Related]
19. Triflusal: an antiplatelet drug with a neuroprotective effect?
González-Correa JA; De La Cruz JP
Cardiovasc Drug Rev; 2006; 24(1):11-24. PubMed ID: 16939630
[TBL] [Abstract][Full Text] [Related]
20. Study on the interaction between Cu phen2+3 and bovine serum albumin by spectroscopic methods.
Zhang YZ; Zhang XP; Hou HN; Dai J; Liu Y
Biol Trace Elem Res; 2008 Mar; 121(3):276-87. PubMed ID: 17960331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
